Gainder Shalini, Thakur Monika, Saha S C, Prakash Mahesh
Department of Obstetrics & Gynaecology, PGIMER Chandigarh, India.
Department of Obstetrics & Gynaecology, PGIMER Chandigarh, India.
Pregnancy Hypertens. 2019 Jan;15:12-15. doi: 10.1016/j.preghy.2018.02.011. Epub 2018 Feb 26.
To compare the efficacy of intravenous labetalol or oral nifedipine in treatment of acute maternal hypertension and study the fetal hemodynamic changes using color Doppler ultrasound that follows treatment.
Thirty women with severe preeclampsia having acute hypertension (more than or equal to 160/105 mmHg) were randomized in 2 groups to receive intravenous labetalol or oral nifedipine until blood pressure was lowered to less than or equal to 140/90 mmHg. Doppler vascular indices namely pulsatility index, resistance index, S/D ratio of umbilical (UA) and middle cerebral artery (MCA) were measured baseline at the time of acute severe hypertension and repeated after control of blood pressure, to assess the changes in fetal hemodynamics if any with labetalol or nifedipine.
Both nifedipine and labetalol were found to be effective when used for rapid control of blood pressure. Mean age of women in both groups and mean gestational age was statistically comparable. No change in fetal heart rate before and after treatment was observed in both groups. Doppler vascular indices of UA and MCA showed no significant changes as compared to baseline values in both groups.
The use of labetalol and nifedipine were not related to any significant changes in fetal Doppler, which is reassuring about the safety of these drugs when treating acute severe hypertension in pregnancy. Choice between these two drugs should be based on cost, availability respective contraindications, and clinician's experience.
比较静脉注射拉贝洛尔或口服硝苯地平治疗急性孕产妇高血压的疗效,并使用彩色多普勒超声研究治疗后胎儿血流动力学变化。
30名患有严重子痫前期并伴有急性高血压(大于或等于160/105mmHg)的妇女被随机分为两组,分别接受静脉注射拉贝洛尔或口服硝苯地平,直至血压降至小于或等于140/90mmHg。在急性重度高血压发作时测量多普勒血管指数,即搏动指数、阻力指数、脐动脉(UA)和大脑中动脉(MCA)的S/D比值,并在血压控制后重复测量,以评估使用拉贝洛尔或硝苯地平后胎儿血流动力学是否有变化。
发现硝苯地平和拉贝洛尔在用于快速控制血压时均有效。两组妇女的平均年龄和平均孕周在统计学上具有可比性。两组治疗前后胎儿心率均未观察到变化。与基线值相比,两组UA和MCA的多普勒血管指数均无显著变化。
使用拉贝洛尔和硝苯地平与胎儿多普勒的任何显著变化均无关,这对于这些药物在治疗妊娠急性重度高血压时的安全性令人放心。这两种药物的选择应基于成本、可用性、各自的禁忌症以及临床医生的经验。